Search Results - "da Gloria Arruda, Maria"

Prolonged lymphocytosis as the first manifestation of Hodgkin-like adult T-cell leukemia/lymphoma by Bittencourt, Achiléa L., Andrade, Agnes Carvalho, Requião, Cristiane, Arruda, Maria da Gloria Bomfim, Araújo, Iguaracyra

“…Hodgkin-like ATLL is a rare variant of adult T-cell leukemia/lymphoma (ATLL), a disease caused by human T-cell lymphotropic virus type-1 (HTLV-1). At…”
Get full text

Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil by Barbosa, Cynara Gomes, Souza, Claudio Lima, Moura Neto, José Pereira de, Arruda, Maria da Glória Bomfim, Barreto, José Henrique, Reis, Mitermayer Galvão, Goncalves, Marilda Souza

“…Methylenetetrahydrofolate reductase (MTHFR: EC 1.5.1.20) polymorphisms are associated to acute lymphoid leukemia in different populations. We used the…”
Get full text

Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS by De Queiroz Crusoe, Edvan, Leal, Joanna, Santos, Juliana Andrade, Santos, Herbert Henrique de Melo, Santos, Allan de souza, Lucas, Larissa Ferreira, Almeida, Alessandro de M., Chaves, Marcos, Dutra, Daniela Dourado, Hungria, Vania T.M., Salvino, Marco Aurelio, Arruda, Maria da Gloria B.

Get full text

10-Year Real-World Data on Acute Myeloid Leukemia: The Paradigm of a Public Health Center in Brazil by Campos, Camilla C., Caldas, Lorena M., Silva, Lais T., Botura, Monica, Almeida, Alessandro de M., Schriefer, Ana Luzia, Arruda, Maria da Gloria B., Salvino, Marco Aurelio

“…Introduction Acute myeloid leukemia (AML) is the most prevalent acute leukemia in adults and originates from hematopoietic precursor cells that suffers…”
Get full text

Evaluation of Hematopoietic Stem Cell Product As a New Site for Minimal Residual Disease By Next Generation Flow in Multiple Myeloma by Santos, Herbert Henrique de Melo, Ribeiro, Glaciano, Santos, Allan de souza, Chaves, Marcos, Leal, Joanna, Santos, Juliana Andrade, Almeida, Alessandro de M., Salvino, Marco Aurelio, Santos, Mariane Melo, Hungria, Vania, Arruda, Maria da Gloria B., De Queiroz Crusoe, Edvan

“…Introduction- Next generation flow (NGF) is one of the approaches for testing multiple myeloma (MM) minimal residual disease (MRD) over conventional response…”
Get full text

Progression Free Survival (PFS) Analysis of Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients by De Queiroz Crusoe, Edvan, Leal, Joanna, Salvino, Marco Aurelio, Lucas, Larissa Ferreira, Santos, Juliana Andrade, Santos, Herbert Henrique de Melo, Almeida, Alessandro de M., Santos, Allan de souza, Chaves, Marcos, Santos, Mariane Melo, Silva, Sarah Queiroz, Vieira, Lucas de Oliveira, Fonseca, Cleverson Alves, Adorno, Elisangela, Hungria, Vania, Arruda, Maria da Gloria B.

“…Background: Newly drugs access for MM treatment still a challenge in some countries. One of the most available inductions for TE NDMM patients (pts) worldwide…”
Get full text

P-066: Effect of Daratumumab (DARA), Cyclophosphamide (C), T Halidomide (T) and Dexamethasone (D) combination of Lymphocyte populations of transplant eligible newly diagnosed Multiple Myeloma patients by Santos, Allan, Santos, Herbert, Salvino, Marco, santos, Juliana, Queiroz, Sarah, Lucas, Larissa, Almeida, Alessandro, Santos, Mariane, Leal, JOanna, da Gloria Arruda, Maria, torres, Alex, Crusoe, Edvan

“…The CTD combination have both an immunomodulatory and immunosuppressive activity on multiple myeloma (MM) patients (pts) treatment. Dara, an antiCD38-antibody,…”
Get full text

Immune Profiling Evaluation of Newly Diagnose Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients Treated with Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone. Preliminary Results by Santos, Allan de souza, Santos, Herbert Henrique de Melo, Salvino, Marco Aurelio, Silva, Sarah Queiroz, Lucas, Larissa Ferreira, Almeida, Alessandro de M., Santos, Mariane Melo, Santos, Juliana Andrade, Hungria, Vania T.M., Arruda, Maria da Gloria B., Torres, Alex, De Queiroz Crusoe, Edvan

“…Background: CD38-targeting antibody Daratumumab (Dara) has been demonstrating significant improvement in (MM) patient’s survival. Cyclophosphamide (C),…”
Get full text

Preliminary Results of Daratumumab, Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Newly Diagnosed Multiple Myeloma (NDMM) Transplant Eligible (TE) Patients by De Queiroz Crusoe, Edvan, Salvino, Marco Aurelio, Silva, Sarah Queiroz, Santos, Herbert Henrique de Melo, Santos, Allan de souza, Almeida, Alessandro de M., Vieira, Lucas de Oliveira, Fonseca, Cleverson Alves, Lucas, Larissa Ferreira, Leal, Joanna, Santos, Mariane Melo, Santos, Juliana Andrade, Adorno, Elisangela, Hungria, Vania T.M., Arruda, Maria da Gloria B.

“…Background: The inclusion of the CD38-targeting antibody daratumumab (Dara) increases the depth and duration of the response, as demonstrated by Dara-VTd and…”
Get full text

First Description of Upfront Target Therapy Treating AML and Bcll Presented Simultaneously As First Line by Carvalho, Juliana Santos, Silva, Anna Flávia Silva Alves, Silva, Maysa Coité, Santos, Itala Gomes, Aragão, Laryssa Pinto, Lucas, Larissa Ferreira, Santos, Herbert Henrique de Melo, Botura, Mônica, Rêgo, Alex Nano Magalhães, Arruda, Maria da Gloria B., De Queiroz Crusoe, Edvan, Almeida, Alessandro de M., Alves, Renata, Lima, Marianna Batista Vieira, Guimarães, Victor Oliveira Sousa, Salvino, Marco Aurelio

“…The occurrence of acute myeloid leukemia (AML) and chronic lymphoid leukemia (B-CLL) simultaneously is rarely described. We describe a case report of AML and…”
Get full text

Liver Injury after Autologous Hematopoietic Stem Cell Transplant: DILI and SOS by Almeida, Alessandro de Moura, Cotrim, Helma Pinchemel, Fonseca, Dayanne Costa, Alencar, Dora Marcia, Dutra, Daniela Dourado, Santos, Herbert Henrique de Melo, Botura, Monica, Salvino, Marco Aurelio, Arruda, Maria da Gloria Bomfim

“…Introduction: Autologous Hematopoietic Stem Cell Transplant (AHCT) is an integral part of the treatment for many hematological and immunological diseases…”
Get full text

P-172: Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: a quadruplet intensified treatment for transplant eligible newly diagnosed Multiple Myeloma (TE NDMM) patients final results by Crusoe, Edvan, santos, Juliana, Leal, JOanna, Santos, Herbert, santos, Allan, Almeida, Alessandro, Santos, Mariane, Lucas, Larissa, Queiroz, Sarah, Fonseca, Cleverson, Adorno, Elisangela, Vieira, Lucas, Hungria, Vania, Salvino, Marco, da Gloria Arruda, Maria

“…Newly drugs access for MM treatment still a challenge. One of the available inductions for TE NDMM patients (pts) worldwide is cyclophosphamide (C),…”
Get full text

P-173: Impact of Daratumumab (DARA) administration during transplant-eligible newly diagnosed Multiple Myeloma (TE NDMM) induction on stem cell (SC) mobilization count and post-transplant engraftment by Crusoe, Edvan, Almeida, Alessandro, Chaves, Marcos, Salvino, Marco, Nicanor, Jamile, Leal, JOanna, Santos, Herbert, Santos, Allan, Guimaraes, Victor, Dourado, Daniela, Lucas, Larissa, Santos, Mariane, santos, Juliana, da Gloria Arruda, Maria

“…In the MAX Dara study, Dara-CTd was used sequentially close to the pre- and post-ASCT (D-30 and D + 30), in order to take advantage of the Dara as an in vivo…”
Get full text